Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bilcare Inaugurates R&D Center | Contract Pharma

What are you searching for?

Sign in
Breaking News

Bilcare Inaugurates R&D Center

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bilcare recently inaugurated its Centre of Excellence in Pune, India. The site has dedicated R&D sections for Packaging Research, Material Research, Analytical Research, Drug Sensitivity Studies and Package Design. The opening was attended by Dr. APJ Abdul Kalam, India’s former president, and Dr. John L. LaMattina, president of Pfizer Global R&D. Drs. Kalam and LaMattina have recently helped Bilcare develop an anti-counterfeiting product to increase product warrant and traceability, according to a press statement.

Mohan Bhandari, chairman and managing director of Bilcare Limited, remarked, “Bilcare is emerging fast as a knowledge company with unique research capabilities to address the critical challenges of the pharmaceutical industry. With this product and the R&D center launch, we are now in a position to offer complete solutions to our global customers on counterfeiting and ensure better healthcare for tomorrow.”

The Centre is also equipped with Asia’s first integrated Flexo Printing machine, as well as a state-of-the art pilot plant, which was inaugurated by Dr. R Chidambaram, principal scientific advisor to the government of India, according to a press statement.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics